Opinion ID: 2620291
Heading Depth: 3
Heading Rank: 1

Heading: A pharmaceutically acceptable micronized

Text: powder composition at least 98.5% by weight of which is pure budesonide or an ester, acetal or salt thereof, wherein the composition meets the criteria of sterility according to the US Pharmacopoeia [sic] 23/NF18, 1995, pages 1686-1690 and 1963-1975. ’834 Patent col. 11 ll. 48–52 (emphasis added). Claim 50 is similar, but is directed to a suspension including a powder: 50. A pharmaceutically acceptable suspension consisting of a micronized powder composition at least 98.5% by weight of which is pure budesonide or an ester, acetal or salt thereof suspended in an aqueous solution, wherein the suspension meets the criteria of sterility according to the US Pharmacopoeia [sic] 23/NFl8, 1995, pages 1686-1690 and 1963-1975. Id. at col. 13 ll. 55–60 (emphasis added). Claims 2 and 51 depend from claims 1 and 50, respectively, and limit the claimed drug to budesonide.